We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Compounds in Red Wine Activate Fat-Regulating Gene

By Biotechdaily staff writers
Posted on 19 Jul 2004
Researchers working with a mouse model have found that the gene SIRT1 (sirtuin 1) reduces the development of new fat cells and increases fat metabolism, especially in the presence of the red wine component resveratrol, in a manner similar to that previously described for the yeast SIR2 gene.

Investigators at Oregon State University (Corvallis, USA) used mice for calorie restriction studies. More...
They found that SIRT1 activated fat mobilization in white adipocytes. Upon food withdrawal, the Sirt1 protein bound to and repressed genes controlled by the fat regulator PPAR-gamma (peroxisome proliferator-activated receptor-gamma), including genes mediating fat storage. Sirt1 repressed PPAR-gamma by docking with its cofactors NCoR (nuclear receptor co-repressor) and SMRT (silencing mediator of retinoid and thyroid hormone receptors). These findings were reported in the June 17, 2004, issue of Nature.

It had been shown previously that resveratrol, a compound found in grape skins and in red wine, increased the activity of SIR2 in yeast and increased the lifespan of yeast cells up to 70%. The current study revealed that the mouse SIRT1 gene demonstrated a similar response to stimulus by resveratrol.

"When cells were exposed to resveratrol, our studies showed a pretty dramatic reduction in the conversion to fat cells and a lesser but still significant increase in the mobilization of existing fat, or the rate at which the cells metabolized stored fat,” said contributing author Dr. Mark Leid, professor of pharmacology at Oregon State University. "This clearly could be one of the explanations for the health benefits that some researchers believe can be linked to moderate red wine consumption.”

He explained that it would be very premature to suggest that supplements of resveratrol would have any benefits, because this compound oxidizes very quickly and easily loses its metabolic effectiveness. "But we do know that red wine has fairly high levels of the compound, and this study would suggest at least one mechanism for possible health benefits of red wine,” he added. "It may help prevent fat development and storage.”



Related Links:
Oregon State University

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
New
Prefilled Tubes
Prefilled 5.0ml Tubes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.